Peptides Hormone SupportAnti-Aging & Longevity
Sermorelin
GRF 1-29
Bioidentical GHRH fragment used diagnostically and off-label to stimulate endogenous growth hormone.
🚧 Expanded guide coming soon. This compound has PK data and a source — a full overview, mechanism, and dosing guide is pending editorial review.
Pharmacokinetic summary
- Model tier
- Simple (t½ + F, Tmax estimated)
- Half-life
- 0.0 days
- Bioavailability
- 50%
- Typical dose
- 0.15–0.5 mg
Related compounds
CJC-1295 with DAC
Long-acting GHRH analog with a drug-affinity complex that extends half-life to ~6–8 days; weekly dosing.
CJC-1295 without DAC (Modified GRF 1-29)
Short-acting GHRH analog (~30 min half-life) usually paired with a GHRP for pulsatile GH release.
Tesamorelin
N-terminally stabilized GHRH analog approved to reduce excess visceral fat in HIV lipodystrophy.
Comments
Loading comments…